CoreView Advisors was built on a simple premise: growth-stage companies deserve finance leadership that's been in the seat — not on the sidelines.
CoreView Advisors partners with venture-backed biotech and life sciences companies that need experienced leadership across finance, accounting, and operations, from first institutional round through IPO, acquisition, or partnership.
We work exclusively with venture-backed life sciences companies navigating the complexity of clinical-stage operations, capital raises, and board-level governance.
IND-enabling through Phase III, with R&D budgets across multiple programs.
Series A through C, venture debt, and investor-ready models and board materials.
Approaching approval and launch, building the infrastructure to scale.
Weekly standups, Slack, board prep. In the room when it matters.
Right-sized to where you are, built toward where you're going.
We've run the audits, presented to the boards, and closed the raises ourselves.
IPO, acquisition, reverse merger, partnership, or another round. We've led finance through each.
Faisal brings over 20 years of finance and operations leadership in biotech and life sciences. Before founding CoreView, he was the first finance hire at clinical-stage companies and led them through financings, IPOs, audits, and commercial milestones. He sits on the board of the Association of Bioscience Financial Officers (ABFO).
Audits, board reporting, investor relations, capital strategy.
Series A–C raises, venture debt, investor-ready models.
Multi-entity finance across VC portfolio companies at every stage.
SEC reporting, SOX 404, annual audits, ASC 718, collaboration accounting.
AI tools built into modeling, reporting, and close workflows.
Whether you need a fractional CFO, help structuring a raise, or an AI assessment for your finance team — start with a conversation.
Schedule a Conversation